Matches in Wikidata for { <http://www.wikidata.org/entity/Q90747285> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q90747285 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q90747285 description "scientific article published on 30 September 2018" @default.
- Q90747285 description "wetenschappelijk artikel" @default.
- Q90747285 description "наукова стаття, опублікована у вересні 2018" @default.
- Q90747285 name "Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis" @default.
- Q90747285 name "Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis" @default.
- Q90747285 type Item @default.
- Q90747285 label "Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis" @default.
- Q90747285 label "Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis" @default.
- Q90747285 prefLabel "Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis" @default.
- Q90747285 prefLabel "Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis" @default.
- Q90747285 P1433 Q90747285-73E29FC1-4F88-4792-A495-74D1005B9D99 @default.
- Q90747285 P1476 Q90747285-12A40D13-06F1-4554-9D29-35D3EABE9B4B @default.
- Q90747285 P2093 Q90747285-08128D7A-8F55-4083-A6E9-400A5C7CE271 @default.
- Q90747285 P2093 Q90747285-54711A6E-00A4-488E-994F-7F9B033076FA @default.
- Q90747285 P2093 Q90747285-5ABD075B-3D07-4C88-A194-8A06715C17A2 @default.
- Q90747285 P2093 Q90747285-7B4F7562-94A5-43A9-9080-FA252FFE37B7 @default.
- Q90747285 P2093 Q90747285-8EACCB8C-A341-4BCD-B199-EA51CF91CF75 @default.
- Q90747285 P2093 Q90747285-9986653D-717C-48A1-8DD2-5DFC40A28A2E @default.
- Q90747285 P2093 Q90747285-A9F98AB3-5C76-46F8-B5A3-ACC4877E4372 @default.
- Q90747285 P2093 Q90747285-D2DE1F4B-B22E-4725-B5C0-69FE9C8E5D7F @default.
- Q90747285 P2860 Q90747285-2A5310AB-C0FA-440F-BAB0-044E16EA6257 @default.
- Q90747285 P2860 Q90747285-473F7AE7-3598-4FD0-84CA-D7B0421227B4 @default.
- Q90747285 P2860 Q90747285-4D5C280B-0C98-419E-8E69-6860D72BAD06 @default.
- Q90747285 P2860 Q90747285-55439EDB-524E-4208-AF75-B36F4CA4BB60 @default.
- Q90747285 P2860 Q90747285-608087B7-C572-4DEA-A69F-CA1F5DF90006 @default.
- Q90747285 P2860 Q90747285-AC97BE06-E7F6-47B1-A7F9-17187FC86216 @default.
- Q90747285 P2860 Q90747285-B32DBD8E-B06D-4EC2-8932-9B3CC1E51EF5 @default.
- Q90747285 P2860 Q90747285-BBA01177-9046-452D-8C9E-E04A024FB3CE @default.
- Q90747285 P2860 Q90747285-C1A05017-F1F9-40A0-9028-C60E1D6CEE8B @default.
- Q90747285 P2860 Q90747285-C28BE2B0-E259-40BC-BC25-223687DCDB61 @default.
- Q90747285 P2860 Q90747285-C5E38BD8-918F-4E27-88FF-E3E8F3B58538 @default.
- Q90747285 P2860 Q90747285-E8E63629-5AA6-447E-9CC4-4DBCFC712225 @default.
- Q90747285 P304 Q90747285-15803088-FDF8-4CC9-9E49-83D008E12403 @default.
- Q90747285 P31 Q90747285-B2B3343A-F87D-4A0A-B1B0-B0D36F0374E4 @default.
- Q90747285 P433 Q90747285-23710A1A-1598-4596-93CB-B3D4AB59A76B @default.
- Q90747285 P478 Q90747285-10846429-737F-41C5-985B-B9BE2D97E151 @default.
- Q90747285 P577 Q90747285-21CEEB52-A21D-41F8-8C89-3FE0AFF5FB3D @default.
- Q90747285 P698 Q90747285-57A46568-BE65-4CF1-AB72-11DCF11C7F6B @default.
- Q90747285 P921 Q90747285-8812BA1F-E8B9-441D-B4A6-2FE026E0EAA3 @default.
- Q90747285 P921 Q90747285-D3621736-5AC2-4BEB-9925-BDFDAD04B4F2 @default.
- Q90747285 P932 Q90747285-BA3A9C43-B6BA-4A47-84ED-FBCA9F8EBDB5 @default.
- Q90747285 P698 30584550 @default.
- Q90747285 P1433 Q26842053 @default.
- Q90747285 P1476 "Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis" @default.
- Q90747285 P2093 "Akram Miramin-Mohammadi" @default.
- Q90747285 P2093 "Ali Khamesipour" @default.
- Q90747285 P2093 "Alireza Firooz" @default.
- Q90747285 P2093 "Amir Javadi" @default.
- Q90747285 P2093 "Hossein Valian-Keshavarz" @default.
- Q90747285 P2093 "Mahmoud Reza Jaafari" @default.
- Q90747285 P2093 "Mansour Nassiri-Kashani" @default.
- Q90747285 P2093 "Seyed Ebrahim Eskandari" @default.
- Q90747285 P2860 Q21134611 @default.
- Q90747285 P2860 Q28468760 @default.
- Q90747285 P2860 Q34663814 @default.
- Q90747285 P2860 Q36751310 @default.
- Q90747285 P2860 Q37935896 @default.
- Q90747285 P2860 Q38235456 @default.
- Q90747285 P2860 Q38400998 @default.
- Q90747285 P2860 Q39000242 @default.
- Q90747285 P2860 Q39113347 @default.
- Q90747285 P2860 Q41981400 @default.
- Q90747285 P2860 Q46201127 @default.
- Q90747285 P2860 Q46367557 @default.
- Q90747285 P304 "269-275" @default.
- Q90747285 P31 Q13442814 @default.
- Q90747285 P433 "3" @default.
- Q90747285 P478 "12" @default.
- Q90747285 P577 "2018-09-30T00:00:00Z" @default.
- Q90747285 P698 "30584550" @default.
- Q90747285 P921 Q2590966 @default.
- Q90747285 P921 Q412223 @default.
- Q90747285 P932 "6297728" @default.